Source: Annual Congress 2006 - Clinical features of sarcoidosis and other granolomatous disorders
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. L. Baradzina, N. S. Shpakovskaya (Minsk, Belarus). There are no correlations between the level of serum antichlamidia antibodies and clinical course of sarcoidosis. Eur Respir J 2006; 28: Suppl. 50, 3114

Member's Comments

No comment yet.

Related content which might interest you: An association between sarcoidosis and serum immunoglobulin levels Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Correlation of serum TNF-α, IL-4 and sIL-2R levels with radiologic and clinical manifestations in active pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 339s Year: 2003 The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Serum cytokine and antiviral antibody in the clinical course of sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 46s Year: 2003 Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003 Very high levels of serum immunoglobulin E (IgE): A clinical profile of 18 children Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 Is there any clinical application for determining the serum cytokines profile in sarcoid patients? Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 The relationship between serum soluble interleukin-2 receptor levels and disease severity in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 355s Year: 2006 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 The relationship between the serum YKL-40 level and severity of asthma Source: Annual Congress 2012 - Asthma management Year: 2012 SIT follow-up: Measurements of specific IgG and IgG4 serum levels Source: Eur Respir J 2002; 20: Suppl. 38, 507s Year: 2002 The clinical significance of plasma and urine lysophospholipids-producing enzymes in patients with sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Association of serum pneumoproteins with clinical course of COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 The association of serum IgG antibody with symptoms of hypersensitivity pneumonitis Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006 Do serum levels of compleman component and immunoglobulins correlate with the degree of emphysema in cases with chronic bronchitis? Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005 The role of serum pseudomonas aeruginosa antibodies in diagnosis and follow-up of patients with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 Elevated chitotriosidase levels in patient with pumonary tuberculosis: correlation with radiologic extent and degree of smaer positiviy Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017